(Q46944958)

26 December 2017

title

Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes (English)

1 reference

26 December 2017

0 references

1 reference

1 reference

1 reference

2

1 reference

26 December 2017

Patricia Iozzo

3

1 reference

26 December 2017

Juhani Airaksinen

8

1 reference

26 December 2017

Juhani Knuuti

9

1 reference

26 December 2017

Terho Lehtimäki

5

Terho Lehtimäki

1 reference

26 December 2017

11

Pirjo Nuutila

1 reference

26 December 2017

Sirpa Jalkanen

7

Sirpa Jalkanen

1 reference

26 December 2017

Riikka Lautamäki

1

Riikka Lautamäki

1 reference

26 December 2017

Markku Komu

4

Markku Komu

1 reference

26 December 2017

R. Parkkola

10

Riitta Parkkola

1 reference

26 December 2017

author name string

Marko Salmi

6

1 reference

26 December 2017

publication date

14 February 2006

1 reference

26 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

26 December 2017

volume

291

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

E282-90

1 reference

26 December 2017

Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

The effect of insulin and FFA on myocardial glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Palmitate-induced apoptosis can occur through a ceramide-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Glucose uptake in the chronically dysfunctional but viable myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Atherosclerosis as inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Endothelial inflammation in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Diseases of liporegulation: new perspective on obesity and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Coming of age of C-reactive protein: using inflammation markers in cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00604.2005

Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1152/AJPENDO.1999.276.5.E977

Identifiers

DOI

10.1152/AJPENDO.00604.2005

1 reference

26 December 2017

PubMed ID

16478772

1 reference

26 December 2017